CLIFTON, N.J. (Map) - CLIFTON, N.J., May 15 /PRNewswire/ -- Ladies Professional Golf Association (LPGA) Tour Professional Diana D'Alessio is teaming with Endo Pharmaceuticals and the National Headache Foundation to launch the PARtnering Against Menstrual Migraine campaign, an educational initiative to raise awareness about menstrual migraine and how women can effectively manage this condition. The campaign will feature free migraine screenings with headache specialists and appearances by D'Alessio at information booths during select LPGA events in 2008.

Nearly 21 million American women suffer from migraines, and as many as 60 percent of these women experience a migraine attack around the time of their menstrual cycle. "While the exact cause of menstrual migraine is not known, evidence suggests that it is strongly associated with hormonal changes that naturally occur during a woman's monthly menstrual cycle," says Suzanne Simons, executive director of the National Headache Foundation. "Common symptoms of menstrual migraine can include severe headache, nausea and vomiting, which can cause significant limitations in daily activities."

"More than 10 years ago, I started getting headaches around the time of my period, usually about nine or 10 months out of the year," said 33-year-old D'Alessio. "For me, that meant severe head pain and an upset stomach that began a couple of days before my cycle. If I was playing golf, I just tried to push through it."

After years of living with debilitating pain, D'Alessio discussed her symptoms with her doctor. He diagnosed her with menstrual migraine and was able to treat her with a medication that effectively manages her symptoms. D'Alessio now wants to help other women become aware of menstrual migraine and educate them that it can be successfully diagnosed and treated.

"Menstrual migraine is a distinct and treatable condition that differs from other migraines and occurs around the time of a woman's period," said Susan Hutchinson, M.D., Orange County Migraine and Headache Center. "Yet, almost half of all women suffering from migraine have not been diagnosed by a physician for this condition."

While the exact cause of menstrual migraine is not known, evidence suggests it is strongly associated with hormonal changes that naturally occur during the monthly menstrual cycle. Through the PARtnering Against Menstrual Migraine campaign, D'Alessio is encouraging women who think they might be suffering from menstrual migraine to track their symptoms and talk to their healthcare professional for an accurate diagnosis and treatment plan. A menstrual migraine tracker, quiz and more information on the condition can be found at the campaign website, www.partneringagainstmenstrualmigraine.com.

D'Alessio is also helping raise funds for menstrual migraine education through her performance on the LPGA Tour in 2008. For every hole under par D'Alessio plays in competition, Endo Pharmaceuticals will make a donation to the National Headache Foundation to support consumer menstrual migraine education programs. In addition, a matching donation will be made to D'Alessio's charity of choice, the Susan L. Bader Foundation of Hope.

The PARtnering Against Menstrual Migraine campaign is funded by Endo Pharmaceuticals.

About Diana D'Alessio

Diana D'Alessio turned professional in 1997 and tied for sixth at the 2007 LPGA Corning Classic. In 2007, she also recorded her first LPGA career hole-in-one in the second round of the Corona Championship and became the 14th player in LPGA history to card back-to-back eagles on the 12th (par 4) and 13th (par 3) holes.

About Endo Pharmaceuticals

A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), Endo Pharmaceuticals is a fully integrated specialty pharmaceutical company with market leadership in pain management products. The company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at www.endo.com.

About the National Headache Foundation

The National Headache Foundation, founded in 1970, is a non-profit organization which exists to enhance the healthcare of headache sufferers. It is a source of help to sufferers' families, physicians who treat headache sufferers, allied healthcare professionals and to the public. The NHF accomplishes its mission by providing educational and informational resources, supporting headache research and advocating for the understanding of headache as a legitimate neurobiological disease. For more information on headache causes and treatments, visit www.headaches.org or call 1-888-NHF-5552 (M-F. 9 a.m. to 5 p.m. CT).